feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Technology / Startup Apps Tackle Japan's Overprescribed Pills

Startup Apps Tackle Japan's Overprescribed Pills

6 Jan

•

Summary

  • Japanese medical industry slowly adopting digital technology.
  • New chatbot apps aim to treat conditions like insomnia.
  • These prescription-only apps are based on clinical trial efficacy.
Startup Apps Tackle Japan's Overprescribed Pills

The Japanese medical industry, historically reliant on paper records and manual prescriptions, is beginning to embrace digital solutions. A burgeoning trend sees domestic startups launching innovative chatbot-powered applications aimed at treating various health conditions, including insomnia, hypertension, and alcohol addiction.

These prescription-only medical apps stand apart from typical lifestyle applications, emphasizing their clinical validation. Their development is driven by the need to address prevalent issues within the healthcare system, such as the overprescription of medications like sleeping pills.

The efficacy of these digital therapeutic tools has been substantiated through rigorous clinical trials, signaling a shift towards evidence-based digital health interventions in Japan.

This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

NEA: Electric coops receive loans

trending

Micron invests $100B in NY

trending

Walton Goggins felt 'depleted'

trending

Shots fired near CDC HQ

trending

WPL 2026: Women's cricket culture

trending

UDA Nationals dance competition

trending

Rocket Lab stock soars

trending

Georgia snow this weekend

trending

Xavier Worthy successful shoulder surgery

Disclaimer:
Several Japanese startups are launching prescription-only chatbot apps to treat conditions like insomnia and hypertension.
The apps aim to address the issue of doctors overprescribing sleeping pills in Japan.
Yes, these prescription-only apps have demonstrated their efficacy in clinical trials.

Read more news on

Technologyside-arrow

You may also like

HCL Tech Revenue Surges, Profit Dips on One-Time Costs

12 Jan • 22 reads

article image

AI Powers TCM Care in Africa

6 Jan • 8 reads

article image

AI Predicts Liposuction Blood Loss with 94% Accuracy

2 Jan • 76 reads

UTime Secures $10M Smart Health Deal

2 Jan • 68 reads

article image

Medicine Delivery: Convenience or Crisis?

16 Dec, 2025 • 48 reads

article image